Immediate Impact
52 standout
Citing Papers
Advances in diagnosis and treatment of bladder cancer
2024 Standout
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Works of Liren Jiang being referenced
Clinical use of machine learning‐based pathomics signature for diagnosis and survival prediction of bladder cancer
2021
Protoporphyrin IX is a dual inhibitor of p53/MDM2 and p53/MDM4 interactions and induces apoptosis in B-cell chronic lymphocytic leukemia cells
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Liren Jiang | 98 | 102 | 88 | 101 | 25 | 283 | |
| Yosuke Iwatate | 89 | 102 | 85 | 108 | 17 | 275 | |
| Günter Schmidt | 48 | 123 | 50 | 118 | 23 | 333 | |
| Yiquan Jiang | 55 | 84 | 34 | 101 | 24 | 278 | |
| Gareth Bryson | 55 | 58 | 70 | 43 | 20 | 263 | |
| Nicolas Brieu | 39 | 107 | 37 | 103 | 23 | 241 | |
| Junli Shi | 67 | 63 | 65 | 99 | 16 | 320 | |
| Annalisa Nardone | 74 | 75 | 36 | 122 | 24 | 253 | |
| Tiebao Meng | 82 | 53 | 63 | 200 | 19 | 328 | |
| Bernadette Redd | 85 | 153 | 33 | 115 | 22 | 322 | |
| Kaitlin E. Sundling | 46 | 74 | 58 | 55 | 28 | 280 |
All Works
Login with ORCID to disown or claim papers
Loading papers...